206
Participants
Start Date
April 10, 2025
Primary Completion Date
January 9, 2026
Study Completion Date
March 6, 2026
Tonlamarsen
Tonlamarsen will be administered subcutaneously (SC) every 4 weeks during the randomized part of the study
Placebo
Placebo will be administered subcutaneously (SC) every 4 weeks during the randomized part of the study
Richmond University Medical Center, Staten Island
CHEAR Center LLC, The Bronx
Manassas Clinical Research Center, Manassas
York Clinical Research LLC, Norfolk
IMA Clinical Research, Lenoir
Clinical Trials of South Carolina, Moncks Corner
Agile Clinical Research Trials, LLC, Atlanta
Velocity Clinical Reseach, Savannah
Progressive Medical Research, Port Orange
Jacksonville Center for Clinical Research, Jacksonville
Homestead Associates in Research, Inc., Homestead
Suncoast Clinical Research, Inc., New Port Richey
Achieve Clinical Research, LLC, Birmingham
Pinnacle Research Group, Anniston
Holston Medical Group, Kingsport
Olive Branch Family Medical Center, Olive Branch
Oakland Medical Research Center, Troy
Health Concepts, Rapid City
Clinical Investigation Specialists, Inc., Gurnee
Eagle Clinical Research, Chicago
Koch Family Medicine Clinical Research, Morton
Tandem Clinical Research GI, LLC, Marrero
DelRicht Clinical Research - New Orleans, New Orleans
IMA Clinical Research, Monroe
Cardiology and Medicine Clinic, Little Rock
North Hills Medical Research, North Richland Hills
Radiance Clinical Research, Lampasas
Juno Research, LLC, Houston
Synergy Groups Medical, LLC, Missouri City
Sun Research Institute, San Antonio
Advanced Medical Trials, LLC, Georgetown
Central Texas Clinical Research, Austin
Elite Clinical Studies, Phoenix
Del Sol Research Management, LLC, Tucson
American Institute of Research, Los Angeles
North Coast Cardiology, Encinitas
Orange County Research Center, Lake Forest
Clinical Trials Research, Lincoln
ActivMed Practices & Research, LLC, Methuen
Lead Sponsor
Kardigan, Inc.
INDUSTRY